Clinical Research Directory
Browse clinical research sites, groups, and studies.
Comparison of Mirabegron and Tamsulosin for Ureteral Stone Expulsion
Sponsor: Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Summary
This randomized controlled trial compares the efficacy and safety of four treatment strategies for ureteral stone expulsion: Mirabegron alone, Tamsulosin alone, a combination of both, and standard conservative care. Participants diagnosed with ureteral stones will be randomly assigned to one of these four groups. The primary objective is to evaluate the stone expulsion rate within 4 weeks. The study also assesses time to expulsion, pain intensity, analgesic use, and potential side effects.
Official title: A Randomized Controlled Trial Comparing Mirabegron and Tamsulosin for Ureteral Stone Expulsion and Clinical Symptom Improvement
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
500
Start Date
2026-01-01
Completion Date
2030-12-31
Last Updated
2025-12-30
Healthy Volunteers
No
Conditions
Interventions
Mirabegron
50 mg tablet orally once daily.
Tamsulosin
0.4 mg tablet orally once daily.
Locations (1)
Taipei Tzu Chi Hospital
New Taipei City, Taiwan